Berberine and Altered Fasting Glucose
- Conditions
- Glucose Metabolism Disorders
- Registration Number
- NCT05031715
- Lead Sponsor
- Azienda di Servizi alla Persona di Pavia
- Brief Summary
The aim of the study was to evaluate the effectiveness of a food supplement, berberine phytosome, which contributes to the control of blood sugar and the improvement of insulin resistance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
- Fasting blood glucose range:100-125 mg/dl
- Diabetes mellitus
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Changes on carbohydrate profile Changes from baseline carbohydrate profile at 4 weeks and at 8 weeks Glycated hemoglobin (%)
Changes on insulin resistance Changes from baseline insulin resistance at 4 weeks and at 8 weeks Homeostasis Model Assessment (pt), for evaluate insulin resistance if \> 2,4
- Secondary Outcome Measures
Name Time Method Changes on body composition Changes from baseline body composition at 4 weeks and at 8 weeks Fat mass (g), Fat Free Mass (g), Visceral Adipose Tissue (g)
Changes on lipid profile Changes from baseline lipid profile at 4 weeks and at 8 weeks Total Cholesterol (mg/dl), High density lipoprotein Cholesterol (mg/dl), Low density lipoprotein Cholesterol (mg/dl), Triglycerides (mg/dl), Apolipoprotein A (mg/dl), Apolipoprotein B (mg/dl)
Changes on Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] Changes from baseline Incidence of Treatment-Emergent Adverse Events at 4 weeks and at 8 weeks Glomerural Filtrate Rate (ml/min)
Changes on anthropometry Changes from baseline anthropometry at 4 weeks and at 8 weeks Waist circumference (cm)
Trial Locations
- Locations (1)
Mariangela Rondanelli
🇮🇹Pavia, Italy
Mariangela Rondanelli🇮🇹Pavia, ItalyMariangela RondanelliContactmariangela.rondanelli@unipv.it